Multi-centre study of the clinical features and gene variant spectrum of Gitelman syndrome in Chinese children

Qian Shen,Jiemei Chen,Minghui Yu,Zhi Lin,Xiaojuan Nan,Beijun Dong,Xiaoyan Fang,Jing Chen,Guixia Ding,Aihua Zhang,Chunlin Gao,Li Miao,Yuanyuan Xu,Xiaoyun Jiang,Haitao Bai,Jieqiu Zhuang,Xiaojie Gao,Hong Xu
DOI: https://doi.org/10.1111/cge.13913
2021-01-01
Clinical Genetics
Abstract:Based on the Chinese Children Genetic Kidney Disease Database (CCGKDD), we established a pediatric Gitelman syndrome (GS) cohort to explore the phenotype and genotype characteristics. Thirty-two patients with SLC12A3 gene variants were collected. Five cases (16%) were homozygous, 16 (50%) were compound heterozygous, 10 (31%) carried only a single variant, and the other one harbored two de novo variants beyond classification. p.(T60M) was found in eight patients. The average diagnosis age was 7.79 +/- 3.54 years. A total of 31% of the patients were asymptomatic. Muscle weakness was the most common symptom, accounting for 50%. Earlier age of onset (4.06 +/- 1.17 yr vs. 8.10 +/- 3.46 yr vs. 8.61 +/- 3.56 yr, p< 0.05) and lower urinary calcium-creatinine ratio (p = 0.024) were found in the homozygous group than those in the heterozygous and compound heterozygous group. Patients with p.(T60M) variant had an earlier age of onset (4.01 +/- 2.83 yr vs. 6.92 +/- 3.07 yr, p = 0.025) and lower urinary calcium-creatinine ratio (p = 0.056). Thus, more than 30% of GS children have no clinical symptoms. Homozygous variant and the p.(T60M) variant may be associated with earlier onset and lower urinary calcium excretion in Chinese pediatric GS.
What problem does this paper attempt to address?